Aditi Shastri, M.B.B.S.
Shastri, Aditi
Assistant Professor of Medicine
Albert Einstein College of Medicine
Dr. Aditi Shastri, M.B.B.S.
Online Profile:
Dr. Aditi Shastri, M.B.B.S.
David Jacobsohn, MD, ScM is the Division Chief, Blood and Marrow Transplanation at Children's National Hospital in Washington, D.C. Previously, he was at Children’s Memorial Hospital in Chicago, where he served as a member of the Stem Cell Transplant Program staff and as the Director of the Chronic Graft-versus-Host Disease Clinic. He has lectured widely on GvHD/BMT in Europe, Latin America, and the United States. Dr.
Myeloablative (MAC) as compared to reduced-intensity conditioning (RIC) is generally associated with lower relapse risk after allogeneic hematopoietic cell transplantation (HCT) for
For most patients with higher-risk
We aimed to compare fatigue of newly diagnosed patients with
Morphological interpretation is the standard in diagnosing myelodysplastic syndrome (MDS), but it has limitations, such as varying reliability in pathologic evaluation and lack of integration with genetic data. Somatic events shape morphologic features, but the complexity of morphologic and genetic changes make clear associations challenging. This article interrogates novel clinical subtypes of MDS using a machine learning technique devised to identify patterns of co-occurrence among morphologic features and genomic events.
Introduction: Hypomethylating agents (HMA) remain the mainstay of treatment for patients with higher-risk